“…Regarding oncologic safety, the present study reports safety results consistent with those of previous reports [3][4][5][6][7][8][9][10][11][12][13][14]17,18 ; 0 (0%), 1 (6.67%), and 2 (12.5%) cases of ECD, PSP, and CSP were exposed at the margin, respectively. Although not statistically relevant, complications, such as temporary facial nerve paralysis, Frey syndrome, and sialocele, occurred less in the ECD group than in the PSP or CSP group.…”